MoonLake Immunotherapeutics Class A Ordinary Shares MLTX
$12.34
+15.87%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | CURRENT REPORT | 2026-09-30 | View → |
| 10-Q | 10-Q | 2026-08-10 | View → |
| 8-K | CURRENT REPORT | 2026-08-10 | View → |
| 4 | Insider transaction | 2026-07-29 | View → |
| 4 | Insider transaction | 2026-07-23 | View → |
| 4 | Insider transaction | 2026-07-21 | View → |
| 4 | Insider transaction | 2026-07-20 | View → |
| 8-K | CURRENT REPORT | 2026-07-15 | View → |
| 4 | Insider transaction | 2026-07-13 | View → |
| 4 | Insider transaction | 2026-07-02 | View → |
| 8-K | CURRENT REPORT | 2026-06-25 | View → |
| 424B5 | PROSPECTUS SUPPLEMENT | 2026-06-24 | View → |
| 4 | Insider transaction | 2026-06-23 | View → |
| 424B5 | PRELIMINARY PROSPECTUS SUPPLEMENT | 2026-06-22 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-22 | View → |
| 8-K | CURRENT REPORT | 2026-06-22 | View → |
| 4 | Insider transaction | 2026-06-18 | View → |
| 4 | Insider transaction | 2026-06-18 | View → |
| 4 | Insider transaction | 2026-06-18 | View → |
| 4 | Insider transaction | 2026-06-18 | View → |
| 4 | Insider transaction | 2026-06-18 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 8-K | CURRENT REPORT | 2026-06-09 | View → |
| 8-K | CURRENT REPORT | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-05-13 | View → |
| 10-Q | 10-Q | 2026-05-11 | View → |
| 8-K | 8-K | 2026-05-11 | View → |
| DEF 14A | DEF 14A | 2026-04-21 | View → |
| 4 | Insider transaction | 2026-04-16 | View → |
| 4 | Insider transaction | 2026-04-14 | View → |
| 4 | Insider transaction | 2026-04-10 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-04-02 | View → |
| 10-K | 10-K | 2026-02-25 | View → |
| 8-K | CURRENT REPORT | 2026-02-23 | View → |
| 4 | Insider transaction | 2026-01-09 | View → |
| 4 | Insider transaction | 2026-01-09 | View → |
| 4 | Insider transaction | 2026-01-09 | View → |
| 8-K | CURRENT REPORT | 2026-01-08 | View → |
| 4 | OWNERSHIP DOCUMENT | 2025-12-22 | View → |
| 4 | OWNERSHIP DOCUMENT | 2025-12-22 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $12.34
- Market Cap
- $906.39 million
- 52-Week Range
- $5.95 – $62.75
- Average Volume
- 2.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.